Mol. Hum. Reprod. Advance Access originally published online on December 3, 2004
Molecular Human Reproduction 2005 11(1):35-41; doi:10.1093/molehr/gah129
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level
1Departments of Clinical Immunology, 2Immunology, 3Oncology and 4Obstetrics and Gynecology, Umeå University, S-90185 Umeå, Sweden
5 To whom correspondence should be addressed. Email: lucia.mincheva-nilsson{at}climi.umu.se
The local immune privilege of the fetus is created by the placenta. Fas ligand (FasL) expression in trophoblast has been implied as one of the mechanisms of fetal tolerance. However, the expression of membranal FasL by trophoblast has failed to explain this role of FasL. Two objections can be raised: (1) there have been contradictions considering which trophoblast cells, syncytiotrophoblast (ST) or cytotrophoblast, express FasL; (2) in vivo and in vitro studies have shown that the membranal form of FasL evokes inflammatory response and thus may promote fetal rejection. Using different assays and the FasL-specific antibody G247-4 we demonstrate beyond doubt that in vivo, (1) FasL is produced by and stored in the first trimester human ST only and (2) the human ST lacks surface membranal FasL. Instead, FasL, loaded in microvesicles, is stored in cytoplasmic granules. These results complement the recent in vitro studies of the microvesicular form of FasL secretion by cultured trophoblast cells, and suggest that placental FasL is synthesized by villous ST, stored in microvesicular form and secreted as exosomes. Secretion of the exosome-associated form of FasL may be one mechanism by which the placenta promotes a state of immune privilege. Additionally, FasL expression in Hofbauer cells is also demonstrated.
Key words: cytoplasmic granules/electron microscopy/FasL/microvesicles/trophoblast
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. H. Kim, N. R. Bianco, W. J. Shufesky, A. E. Morelli, and P. D. Robbins MHC Class II+ Exosomes in Plasma Suppress Inflammation in an Antigen-Specific and Fas Ligand/Fas-Dependent Manner J. Immunol., August 15, 2007; 179(4): 2235 - 2241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Kim, N. R. Bianco, W. J. Shufesky, A. E. Morelli, and P. D. Robbins Effective Treatment of Inflammatory Disease Models with Exosomes Derived from Dendritic Cells Genetically Modified to Express IL-4 J. Immunol., August 15, 2007; 179(4): 2242 - 2249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Guleria and M. H. Sayegh Maternal Acceptance of the Fetus: True Human Tolerance J. Immunol., March 15, 2007; 178(6): 3345 - 3351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zuccato, E. J. Blott, O. Holt, S. Sigismund, M. Shaw, G. Bossi, and G. M. Griffiths Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation J. Cell Sci., January 1, 2007; 120(1): 191 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Valenti, V. Huber, P. Filipazzi, L. Pilla, G. Sovena, A. Villa, A. Corbelli, S. Fais, G. Parmiani, and L. Rivoltini Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-{beta}-Mediated Suppressive Activity on T Lymphocytes. Cancer Res., September 15, 2006; 66(18): 9290 - 9298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Chaput, C. Flament, S. Viaud, J. Taieb, S. Roux, A. Spatz, F. Andre, J.-B. LePecq, M. Boussac, J. Garin, et al. Dendritic cell derived-exosomes: biology and clinical implementations J. Leukoc. Biol., September 1, 2006; 80(3): 471 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mincheva-Nilsson, O. Nagaeva, T. Chen, U. Stendahl, J. Antsiferova, I. Mogren, J. Hernestal, and V. Baranov Placenta-Derived Soluble MHC Class I Chain-Related Molecules Down-Regulate NKG2D Receptor on Peripheral Blood Mononuclear Cells during Human Pregnancy: A Possible Novel Immune Escape Mechanism for Fetal Survival J. Immunol., March 15, 2006; 176(6): 3585 - 3592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Straszewski-Chavez, V. M. Abrahams, and G. Mor The Role of Apoptosis in the Regulation of Trophoblast Survival and Differentiation during Pregnancy Endocr. Rev., December 1, 2005; 26(7): 877 - 897. [Abstract] [Full Text] [PDF]
|
|